UNSPSC 51314372: Ipecac/phenylephrine/potassium guaiacolsulfonate/promethazine

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class RE503. This VA Drug Class (RE503) classifies this compound as belonging to the group ANTIHISTAMINE/DECONGESTANT/EXPECTORANT.

UNSPSC 51314372 Ipecac/phenylephrine/potassium guaiacolsulfonate/promethazine, a Commodity code, shows minimal relevant recent activity in state and local procurement, as the three opportunities posted under this code since early 2026 address unrelated pharmaceutical and health-supply categories that do not match the code's nominal scope. The Seminole County, Florida IFB (IFB60459723LAS, due July 26, 2023) sought naloxone and drug deactivation systems for community health initiatives, while the Texas Health and Human Services Commission RFI (HHS0017013) explored direct-to-manufacturer prescription programs broadly, and the Minnesota Multistate Cooperative Purchasing Alliance RFP (S1070000015802, due March 26, 2026) addressed generic multi-source pharmaceuticals and OTC products across state and local facilities — none of which align with the specific combination respiratory and cardiovascular ingredients defined by this code. State and local issuers tagging opportunities under this code do not appear to be procuring ipecac-phenylephrine formulations as a distinct product line.

No recent solicitations directly match the commodity scope, making pursuit of this code inadvisable pending evidence of actual demand for this specific formulation in state and local markets.